Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose versus standard-dose trimethoprim-sulfamethoxazole prophylaxis in cirrhosis with ascites
ACTRN12609001076268Phase 2Recruiting
- Sponsor
- Austin Health
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of trimethoprim + sulfamethoxazole in bacterial disease (2 arms), sponsored by Austin Health. Primary endpoints: Incidence of bacterial infection and Incidence of hospital admission for complications of chronic liver disease. Started Nov 2009; status: recruiting.
02
Drugs
trimethoprim + sulfamethoxazole
03
Conditions
bacterial disease
Beyond the preview
Go deeper on ACTRN12609001076268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609001076268.